Deborah J Andrews insider trades: Lineage Cell Therapeutics (LCTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Deborah reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 29, 2021 | LCTX | ↓ Sell | 19,142 | $2.93 | $56K | Direct | Jun 30, 2021 (1d) |
| Mar 23, 2020 | STAA | ↓ Sell | 834 | $27.42 | $23K | Direct | Mar 24, 2020 (1d) |
| Jan 21, 2020 | STAA | ↓ Sell | 106,604 | $42.20 | $4.5M | Direct | Jan 23, 2020 (2d) |
| Nov 14, 2019 | STAA | ↓ Sell | 4,167 | $34.68 | $145K | Direct | Nov 15, 2019 (1d) |
| Apr 4, 2019 | STAA | ↓ Sell | 1,000 | $34.35 | $34K | Direct | Apr 5, 2019 (1d) |
| Mar 22, 2019 | STAA | ↓ Sell | 833 | $38.88 | $32K | Direct | Mar 22, 2019 (0d) |
| Sep 11, 2018 | BTX | ↑ Buy | 1,604 | $2.35 | $4K | Direct | Sep 13, 2018 (2d) |
| May 3, 2018 | STAA | ↓ Sell | 13,331 | $17.60 | $235K | Direct | May 7, 2018 (4d) |
| Mar 22, 2018 | STAA | ↓ Sell | 333 | $16.05 | $5K | Direct | Mar 22, 2018 (0d) |
| Aug 21, 2017 | BTX | ↑ Buy | 2,396 | $2.50 | $6K | Direct | Aug 23, 2017 (2d) |
| Jun 16, 2017 | BTX | ↑ Buy | 2,000 | $2.95 | $6K | Direct | Jun 21, 2017 (5d) |
| May 16, 2017 | BTX | ↑ Buy | 2,000 | $3.21 | $6K | Direct | May 17, 2017 (1d) |
| Aug 26, 2015 | BTX | ↑ Buy | 2,000 | $2.82 | $6K | Direct | Aug 26, 2015 (0d) |
| Sep 4, 2013 | STAA | ↓ Sell | 50,000 | $12.88 | $644K | Direct | Sep 4, 2013 (0d) |
| Aug 20, 2013 | STAA | ↓ Sell | 33,515 | $11.65 | $390K | Direct | Aug 22, 2013 (2d) |
| Aug 13, 2013 | STAA | ↓ Sell | 3,928 | $11.63 | $46K | Direct | Aug 15, 2013 (2d) |
| Aug 12, 2013 | STAA | ↓ Sell | 9,079 | $11.62 | $106K | Direct | Aug 12, 2013 (0d) |
| Aug 7, 2013 | STAA | ↓ Sell | 11,721 | $11.79 | $138K | Direct | Aug 7, 2013 (0d) |
| May 9, 2013 | STAA | ↓ Sell | 5,000 | $8.96 | $45K | Direct | May 9, 2013 (0d) |
| Aug 18, 2011 | STAA | ↓ Sell | 30,000 | $6.59 | $198K | Direct | Aug 19, 2011 (1d) |
| Sep 6, 2006 | STAA | ↓ Sell | 6,100 | $6.85 | $42K | Direct | Sep 7, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LCTX insiders
Open-market trades in the last 12 months
About Deborah J Andrews's insider trades
Deborah J Andrews is an insider at Lineage Cell Therapeutics (LCTX). Since Sep 6, 2006, Deborah has reported 5 open-market purchases worth $28K and 16 sales worth $6.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (32 filings), option exercises (9 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LCTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.